Day One: 15 April 2008 Tuesday
|
08.45 | Guest-of-honour address
|
| |
|
09.00 | BioMedical Asia Joint Keynote Address
|
| |
|
10.00 | Morning refreshments, BioMedical Technology Showcase
session & combined Speed Networking
|
| |
|
11.00 | Chairperson's opening remarks
|
| |
|
| ASIA AS THE NEXT PHARMACEUTICAL HUB: OVERCOMING
ASIA'S SUPPLY CHAIN & LOGISTICS COMPLEXITIES |
|
11.10 | Building Asia as the next biopharmaceutical hub: Managing supply chain complexity and working out the best strategy for basing your operations in Asia to serve the global market
- Strategies for securing health regulatory approvals for new manufacturing sites and/or alternate sites
- Aligning supply chain strategies with business strategies to overcome cross-country regulatory complexities
- Assessing the strategic planning and supply chain integration processes required to ensure successful relocation
|
| | Dr Saul Mashaal, Chairman, Founder & CEO, SciGen
|
11.40 | Ensuring the highest quality of product and customer
satisfaction through a secured and fully compliant Active
Pharmaceutical Ingredients (API) manufacturing and supply
chain network
- Reviewing Sun Pharmaceutical infrastructure and procedures in place to build a highly compliant and state of the art API manufacturing plant to be used as a global competitive edge
- Ensuring that every manufactured product meets with and conforms to internationally accepted standards of quality, purity, efficacy and safety through a secure supply chain network
- Implementing tightly monitored quality assurance and quality control systems to ensure consistent product quality
- Monitoring documentation quality in order to comply with changing international requirements
|
| | Mr Vipul Doshi, Vice President Quality, Sun Pharmaceutical
|
12.10 | Boehringer Ingelheim case study: Transforming the entire
supply chain flow to achieve customer satisfaction, process excellence and to reduce weak supply chain links
- Understanding that an unbroken supply chain can positively impact product quality
- Reassessing process and overall business needs to achieve supply and product reliability
- Defining the KPI of the supply chain process
|
| | Ms Devi Purnama , Head of Supply Chain, PT. Boehringer Ingelheim Indonesia
|
12.40 | Networking luncheon and exhibition visit
|
| |
|
| EVALUATING BEST LOGISTICS PRACTICES IN ASIA'S
PHARMACEUTICAL INDUSTRY |
|
14.00 | Re-inventing your distribution and logistics management
practices to ensure regulatory compliance while
maintaining product quality and integrity
- Reviewing new regulatory changes and re-designing your distribution strategy to ensure total compliance
- Evaluating your current logistics vulnerabilities and creating strategic partnerships with your vendors to achieve speed to market and enhance customer satisfaction service levels
- Integrating your distribution strategy with your overall supply chain to achieve cost optimisation
- Gaining insights into Eli Lilly's strategies in serving the global market from India and the impact of its growth in the region
|
| | Mr Ashok Bindumadhavan, Director Supply Chain and Manufacturing, Eli Lilly and Company (India) Pvt. Ltd.
|
14.30 | Building a highly integrated and reliable global logistics
and transportation network which can be customised to
principals' needs while ensuring country to country
compliance
- Evaluating the best temperature sensitive transportation chain to ensure drug effectiveness and quality excellence
- The importance of Good Distribution Practice (GDP) and its impact on supply chain security
- Ensuring that airlines, ocean lines, and trucking companies are compliant with meeting the needs of the industry
- Case studies on integrated and reliable global logistics networks for the pharmaceutical industry
|
| | Mr Matt Brand , Senior Vice President, Vertical Markets , Ceva Logistics
|
15.00 | Maintaining the integrity of the pharmaceutical cold chain: Ensuring temperature sensitive materials are fully compliant across the entire global distribution network
- Understanding the growth of customised packaging and the need for a more flexible cold chain approach
- How to ensure total compliance and product integrity in getting your temperature sensitive materials across changing climate conditions
- Ensuring temperature control and validation through the use of a variety of cold chain service providers: Assessing product combinations to ensure total compliance
|
| | Mr Andrew McDonald , Director Operations Asia Pacific , World Courier
|
15.30 | Afternoon refreshments, exhibition visit & Speed Networking
|
| |
|
| SPEED TO MARKET: TRANSPORTATION, PACKAGING AND
DISTRIBUTION STRATEGIES |
|
16.30 | Asian Pharmaceutical Manufacturers Panel
- Evaluating critical logistics and supply chain challenges in operating within Asia's fragmented trade and logistics networks
- Collaboration strategies: Getting the most out of your partnerships with international versus local 3PLs and third party solutions vendors
- Analysing how the pharmaceutical supply chain will evolve over the next 5-10 years
- Understanding the impact of an economic slowdown on the pharmaceutical industry and identifying how Chief Supply Chain Officers should adapt their supply chains to prepare for economic shocks
|
| | Dr Saul Mashaal, Chairman, Founder & CEO, SciGen Mr Ivan Low, Director Material Handling, Pfizer Asia Pacific Pte Ltd Mr Ashok Bindumadhavan, Director Supply Chain and Manufacturing, Eli Lilly and Company (India) Pvt. Ltd. Mr Oscar Radoc, Head Of Logistics , Operations Service Group, Merck Philippines
|
17.30 | Chairperson's closing remarks
|
| |
|
18.00 | Close of Conference Day One
|
| |
|
19.00 | BioMedical Asia Gala Dinner
|
| |
|
|
Day Two: 16 April 2008 Wednesday
|
08.50 | Chairperson's opening remarks
|
| |
|
| BUILDING A RESPONSIVE END-TO-END GLOBAL SUPPLY CHAIN |
|
09.00 | Keynote Address: Optimising your global end-to-end supply chain to evolve with your organisation's growth and changing market
needs
- Understanding the need for change across the entire pharmaceutical industry's supply chain and logistics practices
- Reviewing the impact of evolving regulations and enforcing compliance in building a global end-to-end supply chain
- Ensuring that your global logistics and supply chain networks are fully compliant
- Streamlining the supply chain process to achieve bottomline success
|
| | Mr Jayant Dwivedy, President, Global Supply Chain, Nicholas Piramal India Limited
|
09.30 | Reducing supply chain cost through effective and
responsive procurement and inventory planning
- Utilising strategic sourcing and procurement planning to ensure the availability of raw materials to meet export demand
- Improving the bottom-line with effective inventory management for raw and finished products by reducing excess inventory at various supply points
• Collaborating with your suppliers and 3PL providers to achieve better response rates and on-time deliveries of raw materials for production
|
| | Mr Robert Luanzon, Head Of Supply Chain , Baxter Healthcare
|
10.00 | Launching Liege Biologistics, the leading bio-hub in Europe
- Presenting the objectives and incentives of the first integrated platform of services and solutions for biologistics in Europe
- Focusing on the specific shipping, supply chain and distribution needs of biopharma, medtech and biotech products
- Supporting the development of infrastructure and investment plans and the organization of training programs for biologisticians
|
| | Mr Serge Pampfer, Co-leader of the BLgEurope Steering Committee and Managing Director, Wallonia Biotech Coaching
|
10.30 | Morning refreshments & exhibition visit
|
| |
|
| STRATEGIC SUPPLY CHAIN PLANNING AND DEMAND FORECASTING |
|
11.30 | Case study on Roche's strategies to reconcile sales and
demand forecasting through efficient SCM planning
- Methodologies to measure sales and demand forecasting: The Roche experience
- Integrating demand forecasting into supply chain models
- How Advanced Planning Systems and enhanced demand planning capabilities impact inventory optimisation
|
| | Ms Mary Rose Claro , Head Of Supply Chain, Roche Philippines Inc.
|
12.00 | Jubilant Organosys case study: Enhancing inventory
management capabilities to achieve supply chain visibility, cost optimisation and to increase service levels
- How to increase visibility within inventory management
- Increasing inventory turns without sacrificing service levels
- Obtaining lower prices through smart volume purchases to prevent slow moving inventory
- Utilising Lean and Six Sigma, Supply Chain Operations Reference ( SCOR) framework for inventory management
|
| | Mr Shyam Bang, Executive Director, Manufacturing and Supply Chain , Jubilant Organosys
|
12.30 | Understanding strategies in driving cost optimisation in
Abbott's logistics and supply chain functions through
continuous improvement
- Evaluating which areas of logistics and supply chain need to be streamlined and improved
- Understanding the drivers behind cost and setting up clear KPIs for each supply chain function
- Building a pro-active/creative/productive logistics team to achieve supply chain efficiency
|
| | Ms Pony Ma, Head Of Logistics, Abbott Laboratories
|
13.00 | Networking luncheon and exhibition visit
|
| |
|
| ENHANCING QUALITY, SAFETY AND PRODUCT INTEGRITY THROUGH KEY SUPPLY CHAIN TECHNOLOGY APPLICATIONS |
|
14.30 | Building a more secure and reliable supply chain network
- Implementing technologies patent safety as the primary goal?
- Examining how RFID-based technology helps pharmaceutical companies to increase bottom-lines, reduce financial loss due to drug counterfeiting
|
| | Mr Peter Schmalleger, Marketing Manager, NXP Semiconductor
|
15.00 | Panel: Understanding how technologies are currently being
adopted to drive supply chain excellence in the
pharmaceutical industry and identifying competitive
opportunities available
- Assessing the role IT has in supporting a global supply chain network
- Aligning technological platforms to ensure true supply chain visibility
- Evaluating current software available to assist supply chain operations and the impact this has on IT infrastructure
- Key challenges and strategies in overcoming the validation and consolidation of technologies
- Identifying the high priority areas for technological development that is pertinent achieve secure and fully compliant supply chains
|
| | Mr Jayant Dwivedy, President, Global Supply Chain, Nicholas Piramal India Limited Ms Pony Ma, Head Of Logistics, Abbott Laboratories Ms Mary Rose Claro , Head Of Supply Chain, Roche Philippines Inc. Mr Vipul Doshi, Vice President Quality, Sun Pharmaceutical
|
16.00 | Afternoon refreshments and exhibition visit
|
| |
|
16.30 | U-Turn is a 50 minute panel session whereby conference delegates assume panel roles extemporaneously. Use this opportunity to harness the power of your perspectives at the conference!
- BioLogistics Asia 2008 is YOUR conference, and we are unveiling a
major new knowledge sharing format which allows you to take control of the conference, lead the discussion and debates in the issues that impact you the most.
|
| |
|
17.30 | Chairperson's closing remarks
|
| |
|
18.00 | Close of conference
|
| |
|
|
Pre-conference Masterclass: 14 April 2008 Monday
|
| Masterclass B: Cold chain management awareness packaging & monitoring– a hands on experience |
Cold chain transportation is facing increased scrutiny from regulators around the world. To maintain the appropriate temperatures for cold chain shipments in different climatic conditions, it is important for shippers to be equipped with the specialized knowledge and understanding to prepare temperature-controlled shipments.
|
| The masterclass will address the following issues: |
- Cold chain best practices
- Introduction to various types of qualified packaging systems
- How to condition and configure the qualified packaging systems
- Techniques in temperature monitoring and refrigerants replenishment
- What are the Contingency plans for cold chain controls
- The validation of shipping procedures in research, development, production, distribution and storage of medication including shipments for clinical trials.
- Case studies on successful implementation and its benefits
|
| Benefits of attending |
- Understand your legal obligation to meet international regulatory,
manufacturing and safety standards
- Understand how you can reduce risk,financial losses and develop contingency plans due inadequate cold chain management practices
- Understand the proper environment that your temperature sensitive product should be handled and transported
- Evaluate the selection criteria of different types of qualified packaging solution to meet your study or project requirements
|
| Who should attend? |
- Pharmaceutical, Biotechnology firms
- Central Laboratories/Clinical research organizations
- Pharmaceutical and healthcare distributors
- Investigator sites /Project Managers/ Depot Managers
- Medical Directors/ Clinical Trial / Research Managers
- Supply Chain/Logistics/Quality Assurance Managers
|
| About your masterclass leader: |
Andrew McDonald
Director - Operations Asia Pacific
World Courier
Andrew McDonald is Director of Operations - Asia Pacific region for World Courier. In his 15 years with World Courier, Andrew has developed an extensive knowledge in cold chain shipping and has overseen thousands of temperature controlled shipments. These shipments range from fragile research samples, investigational pharmaceuticals and diagnostic specimens for clinical trials.
|
|
Post-conference Masterclass: 17 April 2008 Thursday
|
| Masterclass E: Implementing a well planned RFID strategy across your global supply chain |
Estimates from World Health Organization (WHO) are that, globally, 10 percent of the medical products are counterfeited and the economic loss is predicted US75 billion by 2010.Drugs counterfeiting not only has great impact on pharmaceutical financial situation but undermines the whole healthcare system and presents a high risk to patients health.
This full day masterclass will take you on a step by step journey on how you can test, implement and then roll out an effective RFID strategy for your operations in Asia and world-wide. What is the
business case for the investment in RFID? What types of re-engineering of your business processes is required? How would the integration of the RFID infrastructure with the existing infrastructure be performed?
Learn from leading experts on the latest RFID technology and track and trace systems available in the market. Witness real case study sharing sessions on how RFID can potentially improve on efficiencies, increase product security and increase productivity across your logistics and supply chain operations.
|
| This masterclass will address the following issues: |
- Learn about the growing counterfeit problem in pharma
- Reviewing on FDA issued guidelines on a list of potential drugs
target for counterfeiting
- Authenticating the product down the pharma supply chain
- Learn how you can leverage on RFID technology to combat the
latest challenges in pharmaceutical logistics management like inventory reduction, reverse logistics and smart shelves.
- Return of investment of RFID for pharma
- Evaluate the benefits and risks of implementing RFID across your operations
- Hear and participate in interactive results sharing sessions, and discover stumbling blocks to RFID technology implementation and how to overcome them
- Learn how you can strategically use data generated from RFID to your operational advantage
- Case studies on successful implementation and its benefits
|
| Benefits of attending |
- Get an update on the measures on counterfeit protection
- Learn about successful pilots and roll-outs and best practice
- Be informed of the technology available and cost required to build a secured supply chain
- Recognise the necessity for incorporating RFID technology into your supply chain
- Gain insight into how you can reduce risk and financial losses due to drugs counterfeiting
|
| Who should attend? |
- Business leaders
- Safety and security officers
- Compliance and product integrity managers
- IT and RFID program managers
- Pharmaceutical executives involve in quality, logistics, supply chain
|
| About your masterclass leader: |
Peter Schmallegger
Segment Marketing Manager Pharma
Marketing Manager ICODE
Market Sector RFID, Business Line Identification
NXP Semiconductors
Peter Schmallegger is Segment Marketing Manager responsible for the implementation of RFID in the pharmaceutical supply chain and Marketing Manager for ICODE responsible for the world-wide marketing of the ICODE product family. He supports individual projects with leading manufacturers, logistics companies, system integrators and component suppliers.
|